Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Pharmaceutical company reports first quarter 2005 operating results
June 6th, 2005
NPS Pharmaceuticals, Inc. (NPSP) provided a general business update and reported its operating results for the 3 months ended March 31, 2005. NPS continues to make clinical and regulatory progress with its product candidates. Advancements in the company's research, development, and marketing activities included: The company submitted its new drug application (NDA) for PREOS, its proprietary drug candidate for the treatment of osteoporosis, to the U.S. Food and Drug Administration (FDA). The U.S. filing with the FDA follows the filing of a marketing authorization application (MAA) with the European Medicines Evaluation Agency...
Source: Biotech Business Week (2005-06-06)
|
